首页> Expert opinion on pharmacotherapy> Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications

Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications

导出原文传递

翻译打印收藏纠错

作者： Pham ^[1] ; H.T ; Mesplède ; T

作者单位： Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University AIDS Centre ^[1]

关键词 antiretroviral drug resistance Bictegravir

发布时间 2020-03-18

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Expert opinion on pharmacotherapy

2019年20卷1/6期

385-397页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

点击下载本期目录封面

Expert opinion on pharmacotherapy

2019年20卷1/6期

385-397页

检索历史清除

Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications

Expert opinion on pharmacotherapy

相似文献

Expert opinion on pharmacotherapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Bictegravir in a fixed-dose tablet with emtricitabine and tenofovir alafenamide for the treatment of HIV infection: pharmacology and clinical implications

Expert opinion on pharmacotherapy

相似文献

Expert opinion on pharmacotherapy

相关期刊

检索历史清除